Dr. Anushka H. Patel, MD

Dr. Patel practices at Medical Oncology / Hematology - Shea in Scottsdale, Arizona.

Dr. Patel's NPI, 1831308600, was assigned on May 21, 2007. Dr. Patel graduated from Saint Louis University School Of Medicine in 2004. Dr. Patel holds Arizona license 41880.

Dr. Patel's primary practice is Medical Oncology / Hematology - Shea, at 10460 N 92nd St Suite 101 Suite 101, Scottsdale, AZ 85258-4547. The practice phone is (480) 278-8300.

Dr. Patel's primary practice is Medical Oncology / Hematology - Shea in Scottsdale, Arizona. Dr. Patel is also affiliated with HonorHealth Deer Valley Medical Center. The medical group on file is Arizona Center for Cancer Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Patel is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Patel's licenses on file in 2 states: Arizona and Michigan.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Patel treats.

CMS data shows 3,447 Medicare services from Dr. Patel across 26 procedure codes in 2024, for 328 Medicare patients. Medicare paid $658,215 for them. Every service was in an office.

CMS counts 328 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have cancer, and 75% have high cholesterol. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 70, with 72% women.

In 2024, Dr. Patel wrote 139 Medicare Part D claims for 74 patients. 78% of them were for generic drugs. CMS names the drug for 87 of them, across 4 drugs with 11 or more claims each, at $1,209 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Patel, published from 2012 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Decision Making. Dr. Patel has published most often in Ann Surg Oncol. Dr. Patel's most frequent co-authors are David T. Rock, MD, Sheree Elise Brown, MD and Naamit Kurshan Gerber, MD.

Dmand AI links Dr. Patel to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 104 general payments to Dr. Patel from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $4,122.

Dmand AI lists 3 awards for Dr. Patel, most recently Top Doctor-Radiation Oncology Featured Profile in 2016.

Dr. Patel graduated from Saint Louis University School Of Medicine in 2004.

Dr. Patel is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.